Modifi Biosciences
At Modifi Bio, we are changing the oncology treatment paradigm by developing therapeutics that uniquely target specific acquired cancer cell DNA mutations.
Employees
Enterprise value
$17—26m
loading funding rounds…
HighCape Partners(exited)
Connecticut Innovations(exited)
National Cancer Institute (NCI)(exited)
Advantage Capital(exited)
BrightEdge(exited)
Pathway Bioventures(exited)
Brain Tumor Society(exited)
Sontag foundation(exited)
Yale University(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads